Compass Therapeutics, Inc. (CMPX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.38+0.42%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CMPX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | — | — | 0.9 | 0.0 | — | — | — | — |
| Operating Expenses & Income | ||||||||
| R&D Expenses | — | 56.0 | 42.3 | 38.1 | — | — | 14.9 | — |
| Operating Income | (81.1) | (72.8) | (56.6) | (50.4) | (41.7) | (81.9) | (27.8) | (0.0) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | — | — | — | 0.0 | 0.4 | 0.9 | 0.0 |
| Interest & Investment Income | — | 6.4 | 7.3 | 7.9 | 2.4 | 0.0 | 0.1 | — |
| Net Interest Expenses | — | — | — | — | (2.4) | 0.3 | 0.8 | — |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | (1.7) | — |
| EBT, Incl. Unusual Items | — | — | — | (42.5) | (39.2) | (82.2) | (29.5) | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Income | ||||||||
| Net Income | (73.4) | (66.5) | (49.4) | (42.5) | (39.2) | (82.2) | (29.5) | (0.0) |
| Per Share | ||||||||
| Basic EPS | (0.39) | (0.42) | (0.36) | (0.33) | (0.37) | (1.31) | — | — |
| Basic Weighted Avg Shares | 186.8 | 157.7 | 137.4 | 127.0 | 105.2 | 62.9 | — | — |
| Supplemental | ||||||||
| EBITDA | — | (72.6) | (56.0) | (49.7) | (40.9) | (81.3) | (25.4) | — |
| EBIT | (81.1) | (72.8) | (56.6) | (50.4) | (41.7) | (81.9) | (27.8) | (0.0) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | -0.1% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.